This is a $230,817.53 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Connecticut Agricultural Experiment Station (CAES), a state government research entity. The contract is for the evaluation of the efficacy of fall application of synthetic versus natural acaricides (pesticides that kill ticks and mites). This contract does not have a set-aside designation. CAES, the prime contractor, has a history of receiving federal grants and...
This firm fixed-price purchase order, valued at $315,000.00, was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Connecticut Agricultural Experimental Station (CAES) for the evaluation of vegetation management. The CAES, a state government entity, has extensive experience providing environmental and pest management services to federal agencies including the CDC, National Institutes of Health, and Department of Agriculture. This...
The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to Tick Box Technology Corporation, a for-profit manufacturer located in Norwalk, Connecticut. The $90,397.00 contract is for the delivery of the Tick Box Tick Control System, including 4,957 master units and 150 shrouds, to be delivered in two shipments in March and June 2020. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the agency determined...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price definitive contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for tick management services. The contract, valued at $97,035.00, will run from September 26, 2023 to March 31, 2025, and will involve tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods for the CDC's Pittsburgh office. This award is...
This is a 2020 contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Genesis Laboratories, Inc., a for-profit subchapter S corporation. The $149,147 firm fixed-price contract is for products and services related to vector-borne disease research and prevention, specifically controlling tick populations and reducing Lyme disease incidence. Under this definitive contract, Genesis Laboratories will provide fipronil-laced...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for a Feasibility Tick Disease Management effort. The $230,000.00 contract, which has a completion date of September 10, 2022, is focused on tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods. The contract does not have...
The Centers for Disease Control and Prevention awarded a $98,669.98 firm fixed price purchase order to Colorado State University under a sole source solicitation. The contract is for tick surveillance bioinformatics pipeline development to obtain a bioinformatics pipeline to support CDC's tick-borne disease surveillance efforts. Performance will take place in Fort Collins, Colorado over a three year period concluding in May 2023. No subcontractors or set aside designations were identified....
This is a $620,310.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced oral bait. The contract, which has an ultimate completion date of August 24, 2026, is intended to support the CDC's vector-borne disease program by controlling tick populations and reducing Lyme disease incidence. Genesis Laboratories has previously conducted...
This is a firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced bait to control immature Ixodes scapularis ticks in rodents. The contract has a total ceiling value of $249,940.00 and a completion date of September 23, 2024. Genesis Laboratories has previously received multiple federal contracts from the CDC for vector-borne disease research...
The Centers for Disease Control and Prevention awarded a firm fixed price purchase order valued at seventy-four thousand four hundred thirty-five dollars to the Division of Agriculture of the University of Arkansas. The contract supports research to test base and primary layers to inform valid protection against two medically important tick species. As the land-grant institution for the state of Arkansas, the Division of Agriculture will leverage its expertise in agricultural research,...